A previous study showed that the expression and DNA binding of NFκB1/p50 and NFκB2/p52 were enhanced in LCC1 estrogen-independent, TAM-sensitive BC cells compared to MCF-7 estrogen-dependent cells, which further demonstrated a role for NFκB in the pathway to endocrine resistance (345). This evidence concerns the gene NFKB2 and breast cancer.